Real-world epidemiological outcomes of biologic therapy for chronic rhinosinusitis with nasal polyps: a big data analysis
Post-ESS biologic therapy in CRSwNP patients is associated with reduced healthcare utilization and systemic medication use, highlighting its positive impact on disease burden and healthcare efficiency.
Authors
- Elhanan Zloczower
- Y Lahav
- G G Nyquist
- A Bebin
- M Warman
Institutions
- Hebrew University of Jerusalem (IL)
- Kaplan Medical Center (IL)
Publication Details
- Journal
- Rhinology Journal
- Published
- 2025-12-01
- DOI
- https://doi.org/10.4193/rhin25.393
- Primary Topic
- Sinusitis and nasal conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00